| GA20319-1mg |
|
117856-13-0 |
(Tyr⁰)-Atriopeptin II (rat)
|
0 |
C107H165N35O34S2 |
|
|
|
| GA20319-005mg |
|
117856-13-0 |
(Tyr⁰)-Atriopeptin II (rat)
|
0 |
C107H165N35O34S2 |
|
|
|
| GA20318-25mg |
|
132041-95-3 |
(Trp⁷,β-Ala⁸)-Neurokinin A (4-10)
|
0 |
C41H57N9O10S |
|
|
|
| GA20318-5mg |
|
132041-95-3 |
(Trp⁷,β-Ala⁸)-Neurokinin A (4-10)
|
0 |
C41H57N9O10S |
|
|
|
| GA20317-5mg |
|
130154-64-2 |
(Trp⁶³,Trp⁶⁴)-C3a (63-77)
|
0 |
C86H134N26O18 |
|
|
|
| GA20317-1mg |
|
130154-64-2 |
(Trp⁶³,Trp⁶⁴)-C3a (63-77)
|
0 |
C86H134N26O18 |
|
|
|
| GA20316-5mg |
|
156126-74-8 |
|
0 |
C64H82N18O13 |
|
|
|
| GA20316-1mg |
|
156126-74-8 |
|
0 |
C64H82N18O13 |
|
|
|
| GA20315-1mg |
|
1926163-84-9 |
(Trp¹¹,D-Phe¹⁵·¹⁶)-SDF-1 (7-16) (Dimer) (human, cat, mouse)
|
0 |
C134H180N34O26S2 |
|
|
|
| GA20315-005mg |
|
1926163-84-9 |
(Trp¹¹,D-Phe¹⁵·¹⁶)-SDF-1 (7-16) (Dimer) (human, cat, mouse)
|
0 |
C134H180N34O26S2 |
|
|
|
| GA20314-25mg |
|
75644-95-0 |
|
0 |
C80H122N22O19 |
|
|
|
| GA20314-5mg |
|
75644-95-0 |
|
0 |
C80H122N22O19 |
|
|
|
| GA20313-25mg |
|
6120-63-4 |
|
0 |
C51H75N15O11 |
|
|
|
| GA20313-5mg |
|
6120-63-4 |
|
0 |
C51H75N15O11 |
|
|
|
| GA20312-1mg |
|
— |
(Thr⁵⁰⁶)-α-1,3-Glucosyltransferase (500-520)
|
0 |
C106H167N25O30 |
|
|
|
| GA20312-005mg |
|
— |
(Thr⁵⁰⁶)-α-1,3-Glucosyltransferase (500-520)
|
0 |
C106H167N25O30 |
|
|
|
| GA20311-25mg |
|
60786-59-6 |
|
0 |
C39H61N11O12S2 |
|
|
|
| GA20311-5mg |
|
60786-59-6 |
|
0 |
C39H61N11O12S2 |
|
|
|
| GA20310-5mg |
|
77568-41-3 |
(Thr²⁸,Nle³¹)-Cholecystokinin-33 (25-33) (sulfated)
|
0 |
C55H74N14O18S |
|
|
|
| GA20310-1mg |
|
77568-41-3 |
(Thr²⁸,Nle³¹)-Cholecystokinin-33 (25-33) (sulfated)
|
0 |
C55H74N14O18S |
|
|
|
